Literature DB >> 23853074

A genome-wide association study identifies 6p21 as novel risk locus for dilated cardiomyopathy.

Benjamin Meder1, Frank Rühle, Tanja Weis, Georg Homuth, Andreas Keller, Jennifer Franke, Barbara Peil, Justo Lorenzo Bermejo, Karen Frese, Andreas Huge, Anika Witten, Britta Vogel, Jan Haas, Uwe Völker, Florian Ernst, Alexander Teumer, Philipp Ehlermann, Christian Zugck, Frauke Friedrichs, Heyo Kroemer, Marcus Dörr, Wolfgang Hoffmann, Bernhard Maisch, Sabine Pankuweit, Volker Ruppert, Thomas Scheffold, Uwe Kühl, Hans-Peter Schultheiss, Reinhold Kreutz, Georg Ertl, Christiane Angermann, Philippe Charron, Eric Villard, Françoise Gary, Richard Isnard, Michel Komajda, Matthias Lutz, Thomas Meitinger, Moritz F Sinner, H-Erich Wichmann, Michael Krawczak, Boris Ivandic, Dieter Weichenhan, Goetz Gelbrich, Nour-Eddine El-Mokhtari, Stefan Schreiber, Stephan B Felix, Gerd Hasenfuß, Arne Pfeufer, Norbert Hübner, Stefan Kääb, Eloisa Arbustini, Wolfgang Rottbauer, Norbert Frey, Monika Stoll, Hugo A Katus.   

Abstract

AIMS: Dilated cardiomyopathy (DCM) is one of the leading causes for cardiac transplantations and accounts for up to one-third of all heart failure cases. Since extrinsic and monogenic causes explain only a fraction of all cases, common genetic variants are suspected to contribute to the pathogenesis of DCM, its age of onset, and clinical progression. By a large-scale case-control genome-wide association study we aimed here to identify novel genetic risk loci for DCM. METHODS AND
RESULTS: Applying a three-staged study design, we analysed more than 4100 DCM cases and 7600 controls. We identified and successfully replicated multiple single nucleotide polymorphism on chromosome 6p21. In the combined analysis, the most significant association signal was obtained for rs9262636 (P = 4.90 × 10(-9)) located in HCG22, which could again be replicated in an independent cohort. Taking advantage of expression quantitative trait loci (eQTL) as molecular phenotypes, we identified rs9262636 as an eQTL for several closely located genes encoding class I and class II major histocompatibility complex heavy chain receptors.
CONCLUSION: The present study reveals a novel genetic susceptibility locus that clearly underlines the role of genetically driven, inflammatory processes in the pathogenesis of idiopathic DCM.

Entities:  

Keywords:  DCM; Dilated cardiomyopathy; Genome-wide association study

Mesh:

Substances:

Year:  2013        PMID: 23853074     DOI: 10.1093/eurheartj/eht251

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  51 in total

1.  Pathway-based variant enrichment analysis on the example of dilated cardiomyopathy.

Authors:  Christina Backes; Benjamin Meder; Alan Lai; Monika Stoll; Frank Rühle; Hugo A Katus; Andreas Keller
Journal:  Hum Genet       Date:  2015-11-07       Impact factor: 4.132

Review 2.  Genome-wide association studies of late-onset cardiovascular disease.

Authors:  J Gustav Smith; Christopher Newton-Cheh
Journal:  J Mol Cell Cardiol       Date:  2015-04-11       Impact factor: 5.000

Review 3.  Epigenomes: the missing heritability in human cardiovascular disease?

Authors:  Emma Monte; Thomas M Vondriska
Journal:  Proteomics Clin Appl       Date:  2014-08       Impact factor: 3.494

4.  [Ventricular tachycardia : Treatment and prognostic significance].

Authors:  Stephanie Fichtner; Stefan Kääb
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2013-12

Review 5.  Precision medicine approach to genetic cardiomyopathy.

Authors:  K Filonenko; H A Katus; B Meder
Journal:  Herz       Date:  2017-08       Impact factor: 1.443

6.  Identification of a Novel Mucin Gene HCG22 Associated With Steroid-Induced Ocular Hypertension.

Authors:  Shinwu Jeong; Nitin Patel; Christopher K Edlund; Jaana Hartiala; Dennis J Hazelett; Tatsuo Itakura; Pei-Chang Wu; Robert L Avery; Janet L Davis; Harry W Flynn; Geeta Lalwani; Carmen A Puliafito; Hussein Wafapoor; Minako Hijikata; Naoto Keicho; Xiaoyi Gao; Pablo Argüeso; Hooman Allayee; Gerhard A Coetzee; Mathew T Pletcher; David V Conti; Stephen G Schwartz; Alexander M Eaton; M Elizabeth Fini
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-04       Impact factor: 4.799

Review 7.  Genetics of dilated cardiomyopathy: practical implications for heart failure management.

Authors:  Andrew N Rosenbaum; Katherine E Agre; Naveen L Pereira
Journal:  Nat Rev Cardiol       Date:  2019-10-11       Impact factor: 32.419

Review 8.  Genetics of common forms of heart failure: challenges and potential solutions.

Authors:  Christoph D Rau; Aldons J Lusis; Yibin Wang
Journal:  Curr Opin Cardiol       Date:  2015-05       Impact factor: 2.161

9.  Genetic Reduction in Left Ventricular Protein Kinase C-α and Adverse Ventricular Remodeling in Human Subjects.

Authors:  Ray Hu; Michael P Morley; Jeffrey Brandimarto; Nathan R Tucker; Victoria A Parsons; Sihai D Zhao; Benjamin Meder; Hugo A Katus; Frank Rühle; Monika Stoll; Eric Villard; François Cambien; Honghuang Lin; Nicholas L Smith; Janine F Felix; Ramachandran S Vasan; Pim van der Harst; Christopher Newton-Cheh; Jin Li; Cecilia E Kim; Hakon Hakonarson; Sridhar Hannenhalli; Euan A Ashley; Christine S Moravec; W H Wilson Tang; Marjorie Maillet; Jeffery D Molkentin; Patrick T Ellinor; Kenneth B Margulies; Thomas P Cappola
Journal:  Circ Genom Precis Med       Date:  2018-03

Review 10.  Advances in the Genetics and Genomics of Heart Failure.

Authors:  Nosheen Reza; Anjali Tiku Owens
Journal:  Curr Cardiol Rep       Date:  2020-09-10       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.